LifeCell Launches 'PrepaCyte-CB®' Cord Blood Processing Technology as a First in India

LifeCell International, India's premier stem cell bank and mother & child diagnostics company, today announced the introduction of a new premier cord blood processing technology 'PrepaCyte-CB®' which ensures highest yield of stem cells while harvesting stem cells from the baby's umbilical cord blood.

~ Ensures higher yield of stem cells resulting in better transplant outcomes and reduced hospital stay post transplant ~

PrepaCyte-CB® is a sterile, US FDA 510K approved closed processing system manufactured under US FDA's current Good Manufacturing Practices (cGMP). It is a completely closed, sterile system that greatly reduces the chance for contamination during processing. The most important benefit is that PrepaCyte-CB® processed cord blood samples have shown the fastest recovery for patients post stem cell transplantation compared to other methods. This means the patient will spend less time in the vital stage where they don't have an immune system capable of fighting micro-organisms that can cause diseases. Hence effectively this can also translate to less time in the hospital and less stress and worry, waiting for the patient to feel better. Typically, the patient needs to remain at the hospital for 20-21 days whereas with PrepaCyte-CB® transplants, this could potentially be reduced to just 16 days - a significant reduction of time by 20-25% in hospital stay and thereby reduced hospital stay expenses.

In an evidence based study, PrepaCyte-CB® showed extraction of 51% to 70% more viable stem cells when compared to other technologies. Additionally, PrepaCyte-CB® can reduce red blood cell contamination by almost 99% compared to a range of 70-84% in other methods of processing. Fewer red blood cells post-processing means fewer toxic side elements. 

Cryo-Cell International, Inc offers the PrepaCyte-CB® cord blood banking technology to its clients in the U.S after purchasing the rights in 2015. As technology partners, in India, LifeCell shall be the sole company to offer this unique technology.

Mayur Abhaya, Managing Director, LifeCell International, said, "Every effort at LifeCell is aimed towards better treatment outcome and improved patient care. Launch of PrepaCyte-CB® processing technology is another step towards scaling higher quality standards in cord blood processing and commitment to our customers."  

With LifeCell launching the new PrepaCyte-CB® technology, the laboratory and cord blood processing facility at Chennai has been upgraded with complete capabilities to adopt this technology.

Tags : #lifecelllaunchesprepacytecb-cordtechnology

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024